Analysis of 2479 eyes from 2 RCTs and 19 observational studies showed a lower incidence of myopia with anti‐VEGF therapy than laser (RR 0.67; 95% CI 0.54–0.82; Figure 5). Here, VEGFA is linked to myopia.